GABA Signaling

Overview

Gamma-aminobutyric acid (GABA) is the principal inhibitory neurotransmitter in the adult central nervous system. Roughly one in four cortical neurons is GABAergic, and every glutamatergic excitatory volley the brain generates is immediately sculpted and constrained by overlapping waves of GABAergic inhibition. Without this counterweight, cortical circuits collapse into runaway excitation — the mechanism of most generalized seizures.

GABA acts through two distinct receptor systems. GABA-A is an ionotropic, pentameric ligand-gated chloride channel whose opening hyperpolarizes the target neuron within milliseconds. GABA-B is a G-protein coupled, Gi/Go-linked receptor whose activation opens GIRK potassium channels and inhibits voltage-gated calcium channels over hundreds of milliseconds. Together they implement fast phasic inhibition at synapses and slow tonic inhibition across broader membrane patches. Peptides and nootropic molecules such as Selank, DSIP, and Dihexa are studied for their indirect influences on GABAergic tone, memory, and sleep.

How It Works

Synthesis. Glutamate decarboxylase (GAD65 and GAD67 isoforms) converts glutamate — the major excitatory transmitter — to GABA, with pyridoxal phosphate (vitamin B6) as an essential cofactor. This close biosynthetic relationship between excitation and inhibition is metabolically elegant: the brain can shift a molecule between roles by a single decarboxylation step.

Storage and release. Vesicular GABA transporter (VGAT) concentrates GABA into synaptic vesicles. Action potentials in interneurons trigger calcium-dependent vesicular fusion, releasing GABA into the synaptic cleft through the general mechanism described under neurotransmission.

GABA-A receptor. A pentamer typically built from two α, two β, and one γ subunit, with nineteen identified subunit genes permitting tremendous regional and developmental diversity. Agonist binding opens the central chloride-permeable pore, producing fast inhibitory postsynaptic currents that last tens of milliseconds. Benzodiazepines, barbiturates, neurosteroids, propofol, and ethanol all bind distinct allosteric sites on the GABA-A receptor and positively modulate its response to endogenous GABA.

GABA-B receptor. A heterodimer of GABA-B1 and GABA-B2 subunits whose activation opens GIRK channels, closes presynaptic calcium channels, and reduces adenylate cyclase activity. The clinical agonist baclofen treats spasticity by engaging this receptor.

Termination. GABA transporters (GAT-1, GAT-3) clear GABA from the synaptic cleft into neurons and astrocytes, where GABA-transaminase converts it into succinic semialdehyde and ultimately returns carbon to the Krebs cycle.

Interneuron Diversity

Cortical GABAergic interneurons fall into three broad, non-overlapping classes defined by molecular markers: parvalbumin-positive (PV) cells that target pyramidal cell bodies and initial segments with fast, rhythmic inhibition; somatostatin-positive cells that target distal dendrites; and vasoactive intestinal peptide (VIP)-positive cells that preferentially inhibit other interneurons, producing disinhibition. This three-part division, identified by recent single-cell sequencing work, underpins much of the computational richness of cortical microcircuits.

Oscillations

Gamma rhythms (30–80 Hz) require tight reciprocal excitation and inhibition between pyramidal cells and PV interneurons. Theta rhythms (4–12 Hz) in the hippocampus depend on rhythmic GABA release from septal projections. Loss of PV interneuron function in schizophrenia is hypothesized to produce the disrupted gamma-band coherence seen in affected patients during working memory tasks.

Developmental Reversal

In immature neurons, intracellular chloride concentration is unusually high because the KCC2 cotransporter that normally extrudes chloride is not yet expressed. Opening GABA-A channels in this state lets chloride flow outward, depolarizing the cell. Early in development, GABA is therefore excitatory — a seemingly paradoxical condition important for activity-dependent circuit assembly that resolves as KCC2 expression rises postnatally.

Clinical Relevance

Benzodiazepines (diazepam, alprazolam, midazolam) allosterically enhance GABA-A function and produce anxiolysis, sedation, anticonvulsant effects, and muscle relaxation. Z-drugs (zolpidem) act at the same receptor but prefer α1-containing subtypes, yielding selective hypnotic effects. Barbiturates at high doses can directly open GABA-A channels even without GABA, making their overdose far more dangerous than benzodiazepines. Alcohol enhances GABA-A function and simultaneously antagonizes NMDA receptors, a combination that produces its characteristic intoxication and withdrawal profile.

Peptide Interactions

Selank appears to modulate GABA-A expression and may enhance benzodiazepine receptor binding affinity in limbic structures. DSIP is investigated for its promotion of delta-wave sleep, a phenomenon tightly coupled to cortical tonic GABAergic tone and covered under sleep architecture. Dihexa, while primarily known as an HGF mimetic, is studied in circuits where plasticity depends on the inhibitory-excitatory balance GABA maintains.